scorecardresearch
Add as a preferred source on Google
Tuesday, November 25, 2025
TopicCovishield

Topic: Covishield

Not allowing Covishield, Covaxin retail sale meaningless. Indians need vaccines and boosters

ThePrint view on the most important issues, instantly.

Covishield shows increased antibody response to Omicron after 3rd dose: AstraZeneca

Preliminary data released by AstraZeneca shows Vaxzevaria vaccine, administered in India as Covishield, increased immune response to Beta, Delta, Alpha, Gamma variants after third dose.

No trial data on 3 shots of Covaxin, as precaution dose begins from next Monday

Trial on third Covaxin shot ongoing, results to be out soon, says Bharat Biotech. ICMR officials say 9-month interval based on studies that show antibodies last 6-13 months.

Govt says no Covaxin supply issue: 5 cr doses with states, 10 cr more coming in next 2 months

Only Covaxin will be used for vaccinating an estimated 7.4 crore 15-18-year-olds, so finding a slot for the first shot of the indigenous vaccine could get more difficult.

Booster dose of Covishield can increase antibody levels against Omicron, Oxford study says

Antibody levels against Omicron were higher in people who had taken a 3rd Covishield dose than in people who’d had other Covid variants, found a preprint study by Oxford researchers.

Covishield protection wanes after three months, Lancet study finds

The findings drawn from datasets in Brazil and Scotland suggest that booster programmes are needed in those vaccinated with AstraZeneca Covid vaccine, known as Covishield in India.The findings drawn from datasets in Brazil and Scotland suggest that booster programmes are needed in those vaccinated with AstraZeneca Covid vaccine, known as Covishield in India.

India considers ‘mix and match’ for Covid booster shots as calls for third dose grow

No decision has been taken yet on whether booster shots will be given, even as healthcare workers who got fully vaccinated in February near 10 months of vaccination.

ICMR study pushes for Covishield booster doses, says Delta derivatives could reduce efficacy

The study, however, says vaccines will continue to provide sufficient protection against the severity of the disease and fatality, based on breakthrough infections data they analysed.

ZyCov-D supplies to begin soon but may not be part of national vaccine programme right away

With Omicron on the prowl and decision pending on vaccinating children, government may wait before using the one crore doses of ZyCoV-D, the only vaccine licensed for use in minors

Covaxin, Covishield effectiveness highest when gap between doses is 6-8 weeks, ICMR study finds

Covishield is administered in India at an interval of 12-16 weeks, and Covaxin at 4-6 weeks. Study, yet to be peer-reviewed, also says vaccines are effective against Delta and other variants.

On Camera

India shouldn’t copy Taiwan’s currency playbook. It will only lead to instability

Should India opt for a deliberately weakened rupee, it risks compromising its greatest asset: a vast and expanding domestic consumer market.

172 countries & counting, India looks to hit new record in rice exports. But there’s a flip side

The industry forecasts exports are set to grow 16% in 2025-26, boosted by surplus domestic production and a drive to push into 26 underserved global markets with strong potential.

India and France to jointly manufacture HAMMER air-to-surface missile

Indigenisation level will progressively increase up to 60 percent with key sub-assemblies, electronics and mechanical parts being manufactured locally.

A tribute to Tejas. India’s delay culture is the real enemy in the skies

It is a brilliant, reasonably priced, and mostly homemade aircraft with a stellar safety record; only two crashes in 24 years since its first flight. But its crash is a moment of introspection.